Oncology Target Series: Non-Small-Cell Lung Cancer (NSCLC)

Navigating the Complex Landscape of NSCLC Targets

Report
We are delighted to launch Causaly's Oncology Target Series. This month we are zeroing in on targets for NSCLC. Lung cancer is the leading cause of cancer-related deaths in the U.S., and NSCLC is the most prevalent form. With a 5-year survival rate of just 15%, the urgency for more effective treatments has never been greater.
Dive deep into critical areas such as:
  • Target Landscape Overview: Uncover nearly 8,000 targets associated with NSCLC.
  • Target Class Analysis: Understand the distribution of NSCLC targets across different target classes.
  • Genomic Insights: Explore over 100 targets reported in the GWAS catalog.
  • Animal Models: Learn about targets studied in animal models like fruit flies, and zebrafish.
  • Emerging Targets: Discover over 7,000 targets published in the last 5 years.

Request your copy of
Oncology Target Series: Non-Small-Cell Lung Cancer (NSCLC)

Fill out the form below to access the full report.

‌